Knoll Capital Management, LLC - Nov 14, 2024 Form 3 Insider Report for Entera Bio Ltd. (ENTX)

Role
10%+ Owner
Signature
/s/ Fred Knoll
Stock symbol
ENTX
Transactions as of
Nov 14, 2024
Transactions value $
$0
Form type
3
Date filed
11/20/2024, 01:53 PM

Transactions Table

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ENTX Pre-funded warrant Nov 14, 2024 Ordinary Shares, par value NIS 0.0000769 per share 348K $0.00 Direct
holding ENTX Warrants (right to buy) Nov 14, 2024 Ordinary Shares, par value NIS 0.0000769 per share 1.2M $1.00 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

* Gakasa beneficially owns 5,534,275 Shares of the Issuer's Common Stock and 347,604 pre-funded warrants. Each of KCM and Knoll beneficially own 5,534,275 Shares of the Issuer's Common Stock and 347,604 pre-funded warrants. KCM has trading authority for Gakasa, and Knoll is the President of KCM. KCM is a limited liability company formed and existing under the laws of the State of Florida. Knoll is a citizen of the United States. Gakasa is a limited liability company organized under the laws of the State of Florida.